Inventor
ZORN LUDWIG
DE36 patents
⚠️ This page may combine multiple inventors who share the name “ZORN LUDWIG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
Bayer Pharma AG
12 patentsUS9409889B2Aug 9, 2016
Amino-substituted imidazopyridazines
Bayer Pharma AG3 citations72
US11040035B2Jun 22, 2021
3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
Bayer Pharma AG2 citations71
US9708311B2Jul 18, 2017
Benzimidazole derivatives as EP4 antagonists
Bayer Pharma AG2 citations71
US9877954B2Jan 30, 2018
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US9670161B2Jun 6, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations51
US9650340B2May 16, 2017
5-fluoro-N-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
Bayer Pharma AG1 citations51
US10919862B2Feb 16, 2021
Fused imidazoles as mIDH1 inhibitors
Bayer Pharma AG0 citations49
US10214545B2Feb 26, 2019
Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders
Bayer Pharma AG0 citations41
US9783543B2Oct 10, 2017
Aminoimidazopyridazines
Bayer Pharma AG0 citations41
US9745304B2Aug 29, 2017
Amidoimidazopyridazines as MKNK-1 kinase inhibitors
Bayer Pharma AG0 citations41
US9708293B2Jul 18, 2017
N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfone group
Bayer Pharma AG0 citations41
US10130633B2Nov 20, 2018
Compounds
Bayer Pharma AG0 citations39
BAYER SCHERING PHARMA AG
6 patentsUS7615565B2Nov 10, 2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
BAYER SCHERING PHARMA AG3 citations62
US7935827B2May 3, 2011
Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
BAYER SCHERING PHARMA AG0 citations52
US7626035B2Dec 1, 2009
Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters
BAYER SCHERING PHARMA AG0 citations52
US7618957B2Nov 17, 2009
Perfluoroalkyl-containing complexes, process for their production as well as their use
BAYER SCHERING PHARMA AG1 citations51
US7262023B2Aug 28, 2007
Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof
BAYER SCHERING PHARMA AG0 citations49
US7517894B2Apr 14, 2009
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
BAYER SCHERING PHARMA AG0 citations41
SCHERING AG
5 patentsUS7202260B2Apr 10, 2007
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
SCHERING AG11 citations84
US7148357B2Dec 12, 2006
VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
SCHERING AG15 citations83
US6844336B2Jan 18, 2005
4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity
SCHERING AG14 citations83
US6790842B1Sep 14, 2004
11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS
SCHERING AG7 citations73
US6780855B2Aug 24, 2004
11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PROCESS FOR THE PRODUCTION OF PHARMACEUTICAL PREPARATIONS THAT CONTAIN THESE 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES AS WELL AS THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS
SCHERING AG8 citations72
BAYER AG
4 patentsUS11304946B2Apr 19, 2022
2-hetarylpyrimidine-4-carboxamides as aryl hydrocarbon receptor antagonists
BAYER AG2 citations71
US11459312B2Oct 4, 2022
Sulphur substituted 3-oxo-2,3-dihydropyridazine-4-carboxamides
BAYER AG2 citations70
US11524944B2Dec 13, 2022
2-phenylpyrimidine-4-carboxamides as AHR inhibitors
BAYER AG1 citations60
US11591311B2Feb 28, 2023
3-oxo-6-heteroaryl-2-phenyl-2,3-dihydropyridazine-4-carboxamides
BAYER AG1 citations59